Skip to content
10-Q

Quarterly Report

ONCOSEC MEDICAL INCORPORATED

0001493152-23-007478

← back to feed
Filed
Mar 14, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Mar 13, 2023 2.97M sh
Capex Q2 2023 · Jan 31, 2023 $15.96K
Capex Q2 2023 · Jan 31, 2022 $244.86K
Operating Cash Flow Q2 2023 · Jan 31, 2023 −$12.74M
Operating Cash Flow Q2 2023 · Jan 31, 2022 −$19.88M
Cash And Equivalents Q2 2023 · Jan 31, 2023 $3.68M
Cash And Equivalents Q2 2023 · Jul 31, 2022 $12.3M
Stockholders Equity Q2 2023 · Jan 31, 2023 −$5.49M
Stockholders Equity Q2 2023 · Dec 27, 2022 −$2.5M
Stockholders Equity Q2 2023 · Oct 31, 2022 −$984.45K
Stockholders Equity Q2 2023 · Jul 31, 2022 $6.12M
Stockholders Equity Q2 2023 · Jan 31, 2022 $19.82M
Stockholders Equity Q2 2023 · Oct 31, 2021 $28.78M
Stockholders Equity Q2 2023 · Jul 31, 2021 $38.08M
Current Liabilities Q2 2023 · Jan 31, 2023 $7.23M
Current Liabilities Q2 2023 · Jul 31, 2022 $6.63M
Total Liabilities Q2 2023 · Jan 31, 2023 $14.36M
Total Liabilities Q2 2023 · Jul 31, 2022 $15.76M
Current Assets Q2 2023 · Jan 31, 2023 $6.44M
Current Assets Q2 2023 · Jul 31, 2022 $15.23M
Total Assets Q2 2023 · Jan 31, 2023 $8.87M
Total Assets Q2 2023 · Jul 31, 2022 $21.88M
Eps Basic Q2 2023 · Jan 31, 2023 −$2.65
Eps Basic Q2 2023 · Jan 31, 2023 −$6.82
Eps Basic Q2 2023 · Jan 31, 2022 −$5.54
Eps Basic Q2 2023 · Jan 31, 2022 −$11.05
Rd Expense Q2 2023 · Jan 31, 2023 $4.65M
Rd Expense Q2 2023 · Jan 31, 2023 $9.42M
Rd Expense Q2 2023 · Jan 31, 2022 $6.83M
Rd Expense Q2 2023 · Jan 31, 2022 $13.47M
Net Income Q2 2023 · Jan 31, 2023 −$6.86M
Net Income Q2 2023 · Jan 31, 2023 −$14.92M
Net Income Q2 2023 · Jan 31, 2022 −$9.91M
Net Income Q2 2023 · Jan 31, 2022 −$19.72M
Operating Income Q2 2023 · Jan 31, 2023 −$7.66M
Operating Income Q2 2023 · Jan 31, 2023 −$14.97M
Operating Income Q2 2023 · Jan 31, 2022 −$9.42M
Operating Income Q2 2023 · Jan 31, 2022 −$19.33M